- PRICING
- LIVE QUOTES
- LEARN
- HELP
EN
The Math Doesn't Lie: What Oklo's Stock Sales Actually Cost Investors
Key Points
Oklo has run two at-the-money equity offering programs this year to raise capital.
The nuclear technology company has issued 47.7 million new shares since the start of 2025.
The company is working through regulatory hurdles and heavy investments before it can begin operating commercially.
Oklo (NYSE: OKLO) is betting that small-scale nuclear power can play a big role in the future of energy. Its Aurora Powerhouses are advanced small modular reactors (SMRs) designed to make nuclear energy easier to deploy. But bringing first-of-a-kind fast-fission plants to market requires heavy spending for this early-stage company.
To fund that growth, Oklo has repeatedly turned to equity investors. This year alone, the company announced two at-the-market stock-sale programs, each for up to $1 billion. Here is how these stock sales impact Oklo investors.
Missed AI’s "Act 1"? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because they didn't buy Nvidia in 2005. But according to our analysts, we’re only at the end of "Act 1"—the R&D phase. "Act 2" is the global rollout. Continue »
Image source: Getty Images.
Oklo's stock sales have significantly diluted shareholders
On Sept. 11, Oklo announced a $1 billion at-the-market (ATM) stock offering program. An ATM stock offering allows a company to sell newly issued shares into the secondary market over time. This is the second ATM offering program that Oklo has enacted in 2026. In May, the company approved a $1 billion ATM offering and sold nearly 18 million shares at an average price of $55.64.
For investors, ATM offerings mean your stake in the company becomes more diluted. That's because the offering creates new shares for sale in the market, diluting your equity interest in the company.
In another ATM offering in 2025, Oklo sold 12.4 million shares, raising about $1.2 billion. Since the start of 2025, Oklo's shares outstanding have risen from 137.7 million to 185 million, diluting shareholders' stakes by over 25%.
Oklo is a speculative bet on the future of nuclear energy
Early-stage companies like Oklo carry heavy risk. The company is working on advanced nuclear technology, but it will take years before it begins operating commercially. Until then, the company must work through regulatory hurdles, build out its supply chain, and secure fuel for its SMRs.
For those considering buying Oklo stock today, it's important to consider these high costs and dilution risks before investing.
Courtney Carlsen has positions in Oklo. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.